| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |